Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2016 - 2022)

Catalyst Pharmaceuticals (CPRX) has disclosed Other Non-Current Assets for 13 consecutive years, with $9000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other Non-Current Assets changed 0.0% year-over-year to $9000.0, compared with a TTM value of $9000.0 through Dec 2022, changed 0.0%, and an annual FY2022 reading of $9000.0, changed 0.0% over the prior year.
  • Other Non-Current Assets was $9000.0 for Q4 2022 at Catalyst Pharmaceuticals, roughly flat from $9000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $9000.0 in Q4 2020 and bottomed at $8888.0 in Q1 2018.
  • Average Other Non-Current Assets over 5 years is $8938.4, with a median of $8888.0 recorded in 2018.
  • The sharpest move saw Other Non-Current Assets changed 0.0% in 2018, then grew 1.26% in 2020.
  • Year by year, Other Non-Current Assets stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then increased by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
  • Business Quant data shows Other Non-Current Assets for CPRX at $9000.0 in Q4 2022, $9000.0 in Q3 2022, and $9000.0 in Q2 2022.